The National Symposium is an opportunity to gather with the local HD community in your area and learn about the latest in Huntington disease research every two years. The 2017 National Symposium was held on October 14th at 18 volunteer-led locations across Canada, with over 500 people registered to network, and learn from our expert presenters about the latest in HD research.
Presentation One: The Silver Lining: Learning from Unsuccessful HD Clinical Trials
Dr. Tamara Maiuri from McMaster University, shared results of recent HD Clinical trials including Amaryllis, OpenHeart, Premordien and Pride to help us understand why these trials were stopped, but more importantly, what researchers learned that will continue to guide us in the future for treatments of Huntington disease.
Presentation Two: What’s Next? Clinical Trials in HD throughout Canada
Our panel of researchers, including Dr. Mark Guttman from Centre for Movement Disorders, Toronto, Dr. Blair Leavitt from the University of British Columbia, and Dr. Oksana Suchowersky of the University of Alberta each shared the latest news on their research and upcoming clinical trials, including HD-Clarity, Huntingtin Lowering, and GM-1. Moderated by HSC CEO Bev Heim-Myers, this presentation is sure to lead you to Believe!
Thank you to our volunteers, presenters, and staff for all of your efforts in putting together the National Symposium! Stay tuned for details about the 2019 HSC National Symposium!